This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Athira Pharma, Inc.. Active years: 2021-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2025
Title: Jasbir Singh: Innovator in Neurodegenerative Disease Treatment
Introduction
Jasbir Singh is a notable inventor based in Seattle, WA (US). He has made significant contributions to the field of medicine, particularly in the treatment of neurodegenerative diseases. With a total of 2 patents, his work focuses on innovative methods and compounds that address critical health issues.
Latest Patents
Singh's latest patents include groundbreaking technologies for treating neurodegenerative diseases. One of his patents details methods of treating conditions such as dementia, Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis. The technology encompasses compounds, kits, and compositions that are useful for addressing various pathologies, including spinal cord injury, traumatic brain injury, diabetes, metabolic syndrome, and defective wound healing. These advancements aim to improve the quality of life for individuals suffering from these debilitating conditions.
Career Highlights
Jasbir Singh is currently associated with Athira Pharma, Inc., where he continues to develop innovative solutions for complex medical challenges. His expertise and dedication to research have positioned him as a key player in the pharmaceutical industry.
Collaborations
Singh collaborates with esteemed colleagues, including William R Baker and Leen H Kawas. Their combined efforts contribute to the advancement of medical research and the development of effective treatments.
Conclusion
Jasbir Singh's work in the field of neurodegenerative disease treatment exemplifies the impact of innovation in medicine. His patents and ongoing research hold promise for improving patient outcomes and addressing critical health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile